Clinical Trials Browser

OTHER × Neurologic Manifestations × pembrolizumab × Clear all

NCT02313272 2023-10-23

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Phase 1 Completed

32 enrolled 12 charts

Glioma, Neoplasms, Neurologic Manifestations